Skip to main content
. 2022 May 18;23(10):5675. doi: 10.3390/ijms23105675

Figure 5.

Figure 5

Empagliflozin attenuates hepatic steatosis. Livers from control and Empagliflozin-treated mice were isolated, stained for PAS, and imaged. Both male (A) and female (B) control mice fed a high milk-fat diet exhibited severe steatosis. Steatosis scores decreased in all of the Empagliflozin-treated mice with the exception of the SWR/J females where steatosis was not detected. Sev: severe; mod: moderate; min: minimal.